Femoston-conti 1 mg / 5 mg film-coated tablets

Licence status
Authorised: 02/12/2022
Active substances
Estradiol, Dydrogesterone
Dosage Form
Film-coated tablet
Licence number
PPA1463/189/001
Licence holder
IMED Healthcare Ltd.,

Product documents

Licence information

ATC code
G03FA14 dydrogesterone and estrogen
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
02/12/2022